Table 2.
Diabetes and probiotic clinical trials.
Trial identifier | Trail phase (status) | Title | Conditions | Interventions |
---|---|---|---|---|
Diabetes Mellitus type 2 | ||||
NCT01765517 | Completed | Study to Explore the Effects of Probiotics on Endotoxin Levels in Type 2 Diabetes Mellitus Patients | Diabetes Mellitus Type 2 |
|
NCT02728414 | Unknown | Probiotics Effect on Glucose and Lipid Metabolism and Gut Microbiota in Patients With Type 2 Diabetes | Diabetes Mellitus, Type 2 |
|
NCT03377946 | Unknown | Effect of Probiotics on Pre-diabetes and Diabetes in China | Diabetes Mellitus, Type 2 |
|
NCT04089280 | Completed | Probiotics in Metformin Intolerant Patients With Type 2 Diabetes |
|
|
NCT05418179 | Recruiting | Effect of Probiotic Supplementation on Fecal Microbiota, Nutritional Status, Metabolic and Inflammatory Parameters in Patients With Type 2 Diabetes Mellitus | Type 2 Diabetes Mellitus |
|
NCT04988594 | Completed | Effects of Yogurt With Probiotics in Adults With Type 2 Diabetes Mellitus | Type 2 Diabetes |
|
NCT05066152 | Completed | The Effect of Single Probiotic on Metabolic Control in Type 2 Diabetes | Type 2 Diabetes |
|
NCT03434860 | Completed | Effect of Probiotic on Insulin Resistance in Type 2 Diabetes Patients |
|
|
NCT04191525 | Completed | Phase II Clinical Trial to Evaluate the Efficacy and Safety of the Treatment With BPL-1 in Adult Patients With Type 2 Diabetes Mellitus | Type 2 Diabetes |
|
NCT01250106 | Unknown | Probiotics as a Novel Approach to Modulate Gut Hormone Secretion and Risk Factors of Type 2 Diabetes and Complications |
|
Dietary Supplement: Lactobacillus reuteri |
NCT03239366 | Unknown | A Study to Evaluate the Effect of BioK+ 50B® on Glycemic Control in a Type 2 Diabetes Population | Type 2 Diabetes |
|
NCT00413348 | Unknown | Type 2 Diabetes and the Effect of Probiotics |
|
|
NCT01620125 | Completed | Metabolic Control Before and After Supplementation With Lactobacillus Reuteri DSM 17938 in Type 2 Diabetes Patients |
|
Dietary Supplement: Lactobacillus reuteri DSM 17938 |
NCT01752803 | Unknown | RCT Examining Effects of Probiotics in T2DM Individuals |
|
|
NCT00699426 | Completed | The Effect of Nexium and Probiotics on Insulin Secretion and Cardiovascular Risk Factors in Patients With Type 2 Diabetes | Type 2 Diabetes |
|
NCT02274272 | Completed | Effects of Genmont Probiotic on Improve the Level of Blood Glucose and Other Diabetic Associate Parameter in Type 2 Diabetes Patients | Type 2 Diabetes |
|
NCT04296825 | Completed | Effect of Camel Milk With Probiotic on Type 2 Diabetes Mellitus | Type 2 Diabetes |
|
NCT04201938 | Completed | Effect of Probiotic Co-administration With Omega-3 Fatty Acids on Obesity Parameters and Insulin Resistance |
|
|
NCT05076656 | Completed | Epigenetic and Microbiota Modifications |
|
|
NCT02469558 | Completed | Probiotics in Diabesity: A Pilot Study |
|
|
NCT02144948 | Completed | Investigation of the Effect of E.-Coli-Nissle as Supporting Therapy to Standard Care of Diabetes Mellitus Type II | Diabetes type 2 | Drug: e.-coli-nissle |
NCT01836796 | Completed | Metabolic Effects of Lactobacillus Reuteri DSM 17938 in Type 2 Diabetes | Diabetes type 2 |
|
NCT00068094 | Terminated | The Effect of Good Bacteria on Nonalcoholic Fatty Liver Disease in Diabetics |
|
Drug: Probiotic-containing powde |
NCT03037918 | Completed | Effect of Yakult Ingestion on Diet-induced Insulin Resistance in Humans |
|
Dietary Supplement: Yakult light |
NCT01235026 | Unknown | Synbiotics and Low Grade Inflammation in Obese Subjects |
|
|
NCT00655798 | Completed | Effect of Nutritional Interventions on Inflammatory Status in Healthy Overweight Men |
|
|
NCT04767789 | Active, not recruiting | Clinical Trial to Evaluate the Efficacy and Safety of the Probiotic Strains Limosilactocillus Reuteri DSM 32910 and Lacticaseibacillus Paracasei DSM 32851 on Glucose Homeostatis in Prediabetic Adults |
|
|
NCT04341571 | Active, not recruiting | Effect of Probiotics vs Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Prediabetes. |
|
|
NCT04428606 | Completed | Study to Determine the Effect of Synbiotics in Patients With Pre-diabetes | PreDiabetes |
|
NCT04863313 | Recruiting | Effect of a Probiotic on the Glycemic Profile and the Fecal Microbiota of Prediabetic Subjects (PREDIABETCARE) |
|
|
Diabetes Mellitus type 1 | ||||
NCT04579341 | Recruiting | Probiotics Supplementation Effect on Glucose Homeostasis in Children With Type 1 Diabetes | Diabetes Mellitus, Type 1 | Dietary Supplement: Probiotics |
NCT03880760 | Completed | The Effect of Probiotics on Type 1 Diabetes Mellitus in Children | Diabetes Mellitus, Type 1 |
|
NCT03032354 | Unknown | Probiotics in Newly Recognized Type 1 Diabetes | Diabetes Mellitus, Type 1 |
|
NCT03423589 | Completed | Modulation of Type 1 Diabetes Susceptibility Through the Use of Probiotics | Diabetes Mellitus, Type 1 | Dietary Supplement: VSL#3 |
NCT03556631 | Completed | Effect of Live Combined Bifidobacterium and Lactobacillus on Glycemic Control and Other Outcomes in Type 1 Diabetes | Diabetes Mellitus, Type 1 | Drug: live combined Bifidobacterium and Lactobacillus Tablets |
NCT04141761 | Active, not recruiting | Probiotics in Newly Diagnosed T1D | Type 1 Diabetes Mellitus |
|
NCT03961347 | Recruiting | Lactobacillus Johnsonii Supplementation in Adults With T1D | Type 1 Diabetes Mellitus |
|
NCT04335656 | Recruiting | Reducing Innate Inflammation in New Onset Type 1 Diabetes | Type 1 Diabetes Mellitus |
|
NCT03961854 | Recruiting | Lactobacillus Johnsonii in Children and Adolescents With T1D | Type 1 Diabetes Mellitus |
|
NCT04769037 | Recruiting | Supplementation With B. Infantis for Mitigation of Type 1 Diabetes Autoimmunity | Type 1 Diabetes Mellitus |
|